Cancer
Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with stomach cancer and peritoneal metastasis, which is cancer that has spread to the lining of the abdominal cavity.
Latest stories
AI and Digital Health
December 4, 2024
Individualized Medicine
December 3, 2024
Research
December 2, 2024
Research
November 25, 2024
Individualized Medicine
November 21, 2024
Individualized Medicine
November 20, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community